Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Community cohort study of Suxiao Jiuxin Wan for chronic stable angina
ChiCTR-OPC-17011644Phase 4Recruiting
- Sponsor
- Beijing University of Chinese Medicine East Hospital
- Start
- Apr 2017
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of Suxiao Jiuxin Pills in angina pectoris and coronary arteriosclerosis (3 cohorts), sponsored by Beijing University of Chinese Medicine East Hospital. Primary endpoints: Frequency of angina pectoris attacks, Angina pectoris VAS score and 5 more. Started Apr 2017; status: recruiting.
02
Drugs
Suxiao Jiuxin Pills
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-OPC-17011644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17011644.